News

The US Food and Drug Administration's rules on food inspection and product recalls must be updated to avoid a repeat of the 2022 infant formula crisis, a new report has said. Released today by the ...
The Food and Drug Administration (FDA) upgraded a blueberry recall this week to the highest risk level amid concerns of ...
The FDA had "inadequate" policies to heed warnings about infant formula ahead of the 2022 critical shortage, according to HHS' Inspector General.
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs has ended, the Food and Drug Administration announced on Thursday.
Note that some links may require registration or subscription. The FDA classified a nationwide recall of chocolate products ...
From 2019 through 2023, there were 338 Class I medical device recalls, 164 of which were corrections and 174 of which were removals, FDA spokesperson Amanda Hils said. Some products undergo ...
The FDA scrapped its policy of checking all foreign and domestic plants at least once every two years, instead prioritizing checks at facilities based on potential risk to U.S. consumers.
WebMD explains when, why, and how the FDA recalls a medication and what to do if a drug you are taking is a target. ... stores generally have return and refund policies when a recall has been issued.
Recall plans need to be custom-tailored to the FDA-regulated products being marketed, the scope of the company’s operations, and various other factors. 2. Assembling a Recall Team ...
The FDA recall notices show worldwide distribution of more than 22,000 HeartMate 3 devices and more than 2,200 of the HeartMate II. ... an independent source for health policy research, ...
The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to the possible presence of a carcinogen. Duloxetine belongs to a ...
FDA must fix “inadequate” inspection and recall policies, report says. A government watchdog said the FDA was not prepared to deal with a public health crisis such as the 2022 infant formula ...